A novel 18 beta-glycyrrhetinic acid analogue as a potent and selective inhibitor of 11 beta-hydroxysteroid dehydrogenase 2

Bioorg Med Chem Lett. 2004 Jun 21;14(12):3263-7. doi: 10.1016/j.bmcl.2004.03.107.

Abstract

Using 18beta-glycyrrhetinic acid as a template, the synthesis of a series of secondary amides at the 30-position is described and the effects of these modifications on the SAR of the 11beta-hydroxysteroid dehydrogenase isozymes type 1 and 2 from the rat are investigated. An isoform selective inhibitor has been discovered and compound 5, N-(2-hydroxyethyl)-3beta-hydroxy-11-oxo-18beta-olean-12-en-30-oic acid amide, is highlighted as a very potent and selective inhibitor of 11beta-hydroxysteroid dehydrogenase 2 with an IC(50)=4 pM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 11-beta-Hydroxysteroid Dehydrogenase Type 2 / antagonists & inhibitors*
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2 / metabolism
  • Animals
  • Enzyme Inhibitors / chemistry*
  • Enzyme Inhibitors / pharmacology
  • Glucuronides / chemistry*
  • Glucuronides / pharmacology
  • Glycyrrhetinic Acid / analogs & derivatives*
  • Glycyrrhetinic Acid / chemistry*
  • Glycyrrhetinic Acid / pharmacology
  • Rats
  • Rats, Wistar

Substances

  • 18beta-glycyrrhetinic acid-3-O-beta-D-glucuronide
  • Enzyme Inhibitors
  • Glucuronides
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2
  • Glycyrrhetinic Acid